Lipoxin compounds and their use in treating cell proliferative disorders
Abstract:
Compounds having the active site of natural lipoxins, but a longer tissue half-life are disclosed. In particular, 15-epi-lipoxins and their use in ameliorating undesired cell proliferation, which characterizes diseases such as cancer, are also disclosed.
Information query
Patent Agency Ranking
0/0